DEXILANT Trademark

Trademark Overview

On Friday, February 26, 2010, a trademark application was filed for DEXILANT with the United States Patent and Trademark Office. The USPTO has given the DEXILANT trademark a serial number of 77946349. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, March 5, 2021. This trademark is owned by Takeda Pharmaceuticals North America, Inc.. The DEXILANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of gastrointestinal diseases
dexilant

General Information

Serial Number77946349
Word MarkDEXILANT
Filing DateFriday, February 26, 2010
Status800 - REGISTERED AND RENEWED
Status DateFriday, March 5, 2021
Registration Number3887990
Registration DateTuesday, December 7, 2010
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 27, 2010

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the literal element of the mark, "DEXILANT", with an arch design positioned above the "XIL".
Goods and ServicesPharmaceutical preparations for the treatment of gastrointestinal diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 3, 2010
Primary Code005
First Use Anywhere DateFriday, January 30, 2009
First Use In Commerce DateFriday, January 30, 2009

Trademark Owner History

Party NameTAKEDA PHARMACEUTICALS U.S.A., INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameTakeda Pharmaceuticals North America, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameTakeda Pharmaceuticals North America, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameTakeda Pharmaceuticals North America, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Friday, March 5, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, March 5, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, March 5, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, March 4, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 25, 2020TEAS SECTION 8 & 9 RECEIVED
Wednesday, May 20, 2020REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Wednesday, May 20, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 13, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 13, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 13, 2020TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Friday, March 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 13, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, December 7, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, August 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 26, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 26, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 23, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 23, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 11, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, November 19, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 19, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 18, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, September 9, 2016TEAS SECTION 8 & 15 RECEIVED
Monday, December 7, 2015COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, March 8, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 8, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 8, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, December 29, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 7, 2010REGISTERED-PRINCIPAL REGISTER
Thursday, November 4, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 3, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, November 3, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 14, 2010STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 23, 2010USE AMENDMENT FILED
Thursday, October 14, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 23, 2010TEAS STATEMENT OF USE RECEIVED
Tuesday, September 21, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 27, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 27, 2010PUBLISHED FOR OPPOSITION
Monday, June 21, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 21, 2010ASSIGNED TO LIE
Saturday, June 5, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 2, 2010ASSIGNED TO EXAMINER
Thursday, March 4, 2010NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, March 3, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 2, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

dexilant diseases gastrointestinal treatment preparations pharmaceutical